Search Menu

How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation

Reproducibility in preclinical research may be low because of the high prevalence of biases and of suboptimal research practices (such as biased allocation of experimental groups, experimenter bias and lack of necessary controls, the use of uncharacterized materials, poor use of statistics, poor scientific training, etc.). …

Read more

Additional Reads in November 2018

Further commentaries, articles and blog posts worth reading: Meet Octopus, a new vision for scientific publishing Reboot undergraduate courses for reproducibility Losing impact Most Cited versus Uncited Papers. What Do They Tell Us? The changing forms and expectations of peer review Congratulations. Your Study Went Nowhere. …

Read more

Scroll Up